SHLTN — SHL Telemedicine Cashflow Statement
0.000.00%
Last trade - 00:00
- CH₣79.50m
- CH₣78.05m
- $59.00m
- 19
- 39
- 21
- 15
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 10.1 | 5.7 | 0.278 | -13.9 | 0.215 |
Depreciation | |||||
Deferred Taxes | |||||
Non-Cash Items | 2.95 | -0.034 | 0.203 | 14.9 | -3.68 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -4.31 | 1.27 | -0.727 | -6.45 | -3.74 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 12.8 | 10.8 | 4.68 | 0.185 | -0.073 |
Capital Expenditures | -1.25 | -1.97 | -1.77 | -3.26 | -6.9 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 0.505 | 4.45 | -5.88 | -37.7 | 0.471 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Cash from Investing Activities | -0.742 | 2.47 | -7.65 | -41 | -6.43 |
Financing Cash Flow Items | — | — | — | — | -0.13 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -13 | -11.9 | 0.723 | 51.1 | -2.28 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -1.25 | 1.65 | -1.93 | 10.7 | -10.4 |